News
MOTS
--
0.00%
--
Motus GI Announces Publication of a Pure-Vu System® Cost Effectiveness Analysis in the Journal of Cost Effectiveness and Resource Allocation
- - -- The article states Pure-Vu System is estimated to provide lifetime saving of $833- $992 per patient when compared to standard of care for outpatient colorectal cancer (CRC) screening and surveillance colonoscopy - - -- The researchers indicated that...
GlobeNewswire · 2d ago
BRIEF-Motus GI Announces Publication Of A Pure-Vu System Cost Effectiveness Analysis
reuters.com · 2d ago
Motus GI Highlights Publication Of A Pure-Vu System Cost Effectiveness Analysis In Journal Of Cost Effectiveness And Resource Allocation
The article states Pure-Vu System is estimated to provide lifetime saving of $833- $992 per patient when compared to standard of care for outpatient colorectal cancer (CRC) screening and surveillance
Benzinga · 2d ago
Motus GI Holdings, Inc. (MOTS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks · 2d ago
12 Health Care Stocks Moving In Monday's Intraday Session
 
Benzinga · 5d ago
OCGN, AHT, NVAX and VXRT among midday movers
Gainers: Precipio (PRPO) +102%.Regional Health Properties (RHE) +94%.American Shared Hospital Services (AMS) +33%.Brooklyn ImmunoTherapeutics (BTX) +26%.Scully Royalty (SRL) +25%.Ocugen (OCGN) +23%.Top Ships (TOPS) +23%.Rezolute (RZLT) +20%.Milestone Scien...
Seekingalpha · 5d ago
Regional Health Properties, Brooklyn ImmunoTherapeutics leads healthcare gainers; Vaxart, Regulus Therapeutics among major losers
Gainers: Regional Health Properties (RHE) +92%, Brooklyn ImmunoTherapeutics (BTX) +32%, Precipio PRPO +30%, Rezolute (RZLT) +28%, Milestone Scientific (MLSS) +15%.Losers: Vaxart VXRT -18%, Regulus Therapeutics RGLS -18%, Humanigen (HGEN) -12%, Evelo Biosci...
Seekingalpha · 6d ago
This Penny Stock Bounced At A Key Technical Level And Is Heading Back Up
Naked Brand Group LTD. (NASDAQ: NAKD) moved higher Friday after the company announced results from its "extraordinary general meeting." On April 23, shareholders voted for approval of the proposed transaction to divest Bendon brick-and-mortar operations.
Benzinga · 04/30 18:19
NAKD, MOTS, TWTR and MVIS among midday movers
Gainers: Brooklyn ImmunoTherapeutics (BTX) +58%.Regional Health Properties (RHE) +49%.Motus GI Holdings (MOTS) +31%.Bel Fuse (BELFB) +29%.Image Sensing Systems (ISNS) +23%.Farmmi (FAMI) +20%.CryoLife (CRY) +18%.Naked Brand (NAKD) +17%.Laureate Education (L...
Seekingalpha · 04/30 16:40
Brooklyn ImmunoTherapeutics, Motus GI leads healthcare gainers; Ardelyx, Pacific Biosciences of California among major losers
Gainers: Brooklyn ImmunoTherapeutics (BTX) +38%, Motus GI MOTS +32%, CryoLife (CRY) +16%, Mesoblast MESO +14%, Arcutis Biotherapeutics (ARQT) +10%.Losers: Ardelyx (ARDX) -13%, Pacific Biosciences of California (PACB) -13%, ALX Oncology (ALXO) -11%, Keros T...
Seekingalpha · 04/30 15:04
DJ Motus GI Shares Rise 34% on FDA Clearance for Pure-Vu System
Dow Jones · 04/30 14:57
DJ Motus GI Gets FDA Clearance for Pure-Vu System
Dow Jones · 04/30 13:09
Thinking about buying stock in Motus GI, Aurinia Pharmaceuticals, Aptose Biosciences, Vaxart, or Atossa Therapeutics?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MOTS, AUPH, APTO, VXRT, and ATOS.
PR Newswire - PRF · 04/30 12:30
MESO, MOTS and SALM among premarket gainers
Image Sensing Systems (ISNS) +24% on strategic changes.Motus GI Holdings (MOTS) +47% on FDA 510(k) clearance of Pure-Vu System.Tarena International (TEDU) +10% after entering "going private" merger agreement.Salem Media Group (SALM) +9%.Arcutis Biotherapeu...
Seekingalpha · 04/30 12:15
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Benzinga · 04/30 12:14
BRIEF-Motus GI Receives FDA Clearance To Market The Pure-Vu System For Upper Gi Endoscopy
reuters.com · 04/30 11:47
Motus GI shares rocket 55% on FDA 510(k) clearance of Pure-Vu System
Motus GI Holdings (MOTS) soars 55% premarket after receiving 510(k) clearance from the FDA for a version of the Pure-Vu System used during upper gastrointestinal ((GI)) endoscopy procedures to remove blood, blood
Seekingalpha · 04/30 11:43
Motus GI Receives FDA Clearance to Market the Pure-Vu(R) System for Upper GI Endoscopy
FORT LAUDERDALE, Apr 30, 2021 (GLOBE NEWSWIRE via COMTEX) -- FORT LAUDERDALE, Fla., April 30, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ:...
GlobeNewswire · 04/30 11:30
Motus GI Holdings Receives FDA Clearance to Market Pure-Vu System; Shares Surge Pre-Bell
MT Newswires · 04/30 08:01
Motus GI to Release First Quarter Results and Provide a Business Update on May 13
FORT LAUDERDALE, Fla., April 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency assoc...
GlobeNewswire · 04/29 21:01
Webull provides a variety of real-time MOTS stock news. You can receive the latest news about MOTUS GI HOLDING through multiple platforms. This information may help you make smarter investment decisions.
About MOTS
Motus GI Holdings, Inc. is a medical technology company that operates along with its subsidiaries Motus, Ltd. and Motus, Inc. The Company is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The Pure-Vu system uses a precise mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents, clearing the way for the endoscopist to perform a high quality examination, even when the patient is not fully clean prior to their procedure. The Pure-Vu System also helps in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon This device fits standard colonoscopes, allowing the physician to clean poorly-prepped colons in a safe and effective manner to gain clear visualization of the colon mucosa.